GAIN Begins (Part 2): Infectious Disease Society and Start-Up Companies Push for More

The ink is barely dry on new antibiotic incentives in the GAIN Act, but the anti-infective development community is pushing for more. New ideas include “pull” incentives modeled on biodefense programs.